EFF yields 44.51% · JNJ yields 2.14%● Live data
📍 EFF pulled ahead of the other in Year 1
Combined, EFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EFF + JNJ for your $10,000?
Eaton Vance Floating-Rate Income Plus Fund is a diversified closed-end management investment company. The Fund's investment objective is total return, with an emphasis on income. Its secondary objective is preservation of capital. The Fund invests primarily in below investment grade floating-rate loans. Under normal market conditions, the Fund invests approximately 80% of its total assets in senior loans of domestic and foreign borrowers that are denominated in the United States dollars and foreign currencies. Its portfolio includes investments in various locations, such as the United States, Luxembourg, Canada, the Netherlands, Cayman Islands and Australia. Its portfolio of investments includes aerospace and defense, automotive, chemicals and plastics, ecological services and equipment, electronics/electrical, utilities, food products, healthcare, insurance and financial intermediaries. Eaton Vance Management is an investment advisor to the Fund.
Full EFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.